Related Experiment Videos
Immediate breast reconstruction in the high-risk adjuvant setting
P D Wey1, J B Highstein, G L Borah
1Department of Surgery, UMDNJ-Robert Wood Johnson Medical School, New Brunswick 08901-0019, USA.
Annals of Plastic Surgery
|April 1, 1997
Summary
High-dose chemotherapy with autologous stem cell support offers hope for high-risk breast cancer patients. This study explores the feasibility of breast reconstruction for these survivors, aiming to improve quality of life.
Area of Science:
- Oncology
- Surgical Oncology
- Breast Cancer Research
Background:
- High-dose chemotherapy with autologous stem cell support is a treatment option for high-risk primary breast cancer.
- High-risk patients are defined as those with locally advanced disease (stage IIB or higher) and a >50% risk of systemic illness.
- Increasing survival rates in this population necessitate exploring comprehensive treatment and survivorship options.
Observation:
- This report evaluates the feasibility of offering reconstructive breast surgery to high-risk breast cancer patients.
- The study considers the role of surgical reconstruction in the context of improved survival rates.
Findings:
- The study aims to determine if reconstructive breast surgery is a viable option for high-risk breast cancer patients undergoing intensive treatment.
- It investigates the potential for integrating immediate breast reconstruction into the treatment protocols for advanced breast cancer.
Implications:
- As survival improves, reconstructive breast surgery could become a standard offering for high-risk breast cancer patients.
- This could enhance the quality of life for survivors of advanced or high-stage primary breast cancer.